Navigation Links
NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Date:9/10/2007

PORT WASHINGTON, N.Y., Sept. 10 /PRNewswire-FirstCall/ -- National Medical Health Card Systems, Inc. (Nasdaq: NMHC), a national independent pharmacy benefit manager ("PBM"), today reported its results for the fiscal fourth quarter and fiscal year ended June 30, 2007.

Three months ended June 30, 2007

Revenue for the 2007 fiscal fourth quarter was $146.0 million, as compared to revenue of $211.5 million for the same period last year, a 31.0 percent decrease. This decrease is primarily attributable to a decrease in covered lives as compared to last year resulting from the loss of various customers.

For the 2007 fiscal fourth quarter, gross profit was $21.1 million, as compared to $21.7 million for the same period last year, reflecting a decrease of 2.8 percent. The decrease in gross profit is primarily attributable to a $1.0 million reduction from the PBM segment, offset by a $424,000 increase in the Specialty Pharmacy segment. Primarily related to a change in customer mix, gross profit as a percentage of revenue, or gross margin, increased to 14.5 percent for the 2007 fiscal fourth quarter, as compared to 10.3 percent for the same period last year. Adjusted prescriptions for the 2007 fiscal fourth quarter were 5.3 million, as compared to 7.5 million for the same period last year. Gross profit per adjusted prescriptions increased to $3.98 from $2.89 for the same period last year. Adjusted prescription volume equals our Mail Service prescriptions multiplied by three, plus our retail prescriptions. These Mail Service prescriptions are multiplied by three to adjust for the fact that they typically include approximately three times the amount of product days supplied compared with retail prescriptions.

Intangible assets, net 2,551 3,013

Goodwill 99,414 99,319

Other non-current assets 799 1,070

Total Assets $253,089 $272,153

Liabilities, Redeemable Preferred Equity,

and Common Stockholders' Equity

Current Liabilities:

Claims payable to pharmacies $59,508 $88,979

Rebates payable to customers 45,668 60,953

Trade and other payables and

accrued expenses 19,804 10,707

Current portion of capital lease

obligations 989 16

Customer deposits payable 12,244 1,541

Other current liabilities 954 -

Total current liabilities 139,167 162,196

Capital lease obligations, less

current portion 1,486 -

Other non-current liabilities 1,330 829

Deferred tax liabilities 8,780 7,784

Total liabilities 150,763 170,809

Commitments and Contingencies

Redeemable Preferred Equity:

Series A redeemable convertible

preferred stock $.10 par value;

15,000,000 shares authorized,

6,956,522 issued and outstanding,

aggregate liquidation preference

of $111,304,352 76,813 76,338

Common Stockholders' Equity:

Common Stock, $.001 par value,

35,000,000 shares authorized,

10,158,221 and 9,933,697 shares

issued, 5,518,321 and 5,293,797

outstanding, respectively 10 10

Additional paid-in capital 133,120 126,630

Accumulated deficit (55,738) (49,755)

Treasury stock at cost, 4,639,900

shares (51,879) (51,879)

Total common stockholders'

equity 25,513 25,006

Total Liabilities, Redeemable

Preferred Equity, and Common

Stockholders' Equity $253,089 $272,153

NATIONAL MEDICAL HEALTH CARD SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

Three months ended Years ended

June 30, June 30,

2007 2006 2007 2006

(unaudited)(unaudited)

Revenue (excludes participant

co-payments retained by the

pharmacies of $50,836,

$78,012, $249,526 and

$321,055, respectively) $146,038 $211,451 $679,081 $862,853

Cost of claims (excludes

participant co-payments

retained by the pharmacies of

$50,836, $78,012, $249,526

and $321,055, respectively) 124,947 189,744 591,766 771,487

Gross profit 21,091 21,707 87,315 91,366

Selling, general and

administrative expenses 26,036 18,955 87,481 75,852

Operating (loss) income (4,945) 2,752 (166) 15,514

Other income (expense):

Interest expense (166) (67) (516) (313)

Interest income 668 408 1,912 1,462

Other income, net 39 29 60 9

541 370 1,456 1,158

(Loss) income before (benefit)

provision for income taxes (4,404) 3,122 1,290 16,672

(Benefit) provision for income

taxes (1,141) 1,238 1,198 7,015

Net (loss) income (3,263) 1,884 92 9,657

Redeemable convertible

preferred stock cash dividends 1,396 1,396 5,600 5,600

Accretion of transaction

expenses 119 119 475 475

Net (loss) income available to

common stockholders $(4,778) $369 $(5,983) $3,582

Earnings (loss) per common

share:

Basic $(0.87) $0.07 $(1.10) $0.70

Diluted $(0.87) $0.07 $(1.10) $0.67

Weighted-average number of

common shares outstanding:

Basic 5,489 5,291 5,454 5,143

Diluted 5,489 5,413 5,454 5,311

NATIONAL MEDICAL HEALTH CARD SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

Years ended

June 30,

2007 2006 2005

Cash flows from operating activities:

Net income $92 $9,657 $12,381

Adjustments to reconcile net

income to net cash

provided by operating

activities:

Depreciation and amortization 9,777 7,470 6,300

Stock-based compensation

expense 3,799 3,240 -

Amortization of deferred gain (21) (49) (100)

Amortization of deferred

financing costs 113 112 167

Loss on disposal of capital

assets - 38 -

Loss on impairment of capital

assets 657 - -

Provision for doubtful accounts 2,080 200 651

Deferred income taxes 1,204 1,587 2,912

Excess tax benefits from

exercise of stock options (221) (2,255) -

Changes in assets and liabilities:

Restricted cash (14,431) (851) 435

Accounts receivable 17,820 20,564 (27,425)

Rebates receivable 6,494 (8,534) 488

Inventory (584) (1,547) (867)

Due from affiliates - 31 (13)

Prepaid expense and other

current assets (135) 1,160 (3,867)

Other non-current assets 158 113 2,694

Claims payable to pharmacies (29,471) (27,159) 16,401

Rebates payable to customers (15,285) 12,995 11,985

Trade and other payables and

accrued expenses 8,418 (10,889) (19,108)

Customer deposits payable 10,703 (1,389) 2,918

Income taxes payable and other

current liabilities 1,483 3,284 5,289

Other non-current liabilities 522 (120) (919)

Net cash provided by operating

activities 3,172 7,658 10,322

Cash flows from investing activities:

Capital expenditures (5,392) (7,898) (5,795)

Acquisition of PCN, net of cash

acquired - - 3,150

Acquisition of Centrus, net of

cash acquired - - (1,000)

Acquisition of Inteq, net of

cash acquired - 116 (139)

Acquisition of PPP, net of cash

acquired (901) (425) (358)

Acquisition of MPP (266) - -

Proceeds from sale of capital

assets 5 185 -

Net cash used in investing activities (6,554) (8,022) (4,142)

Cash flows from financing activities:

Proceeds from exercise of stock

options 2,319 4,876 4,188

Proceeds from revolving credit

facility - 82,625 724,758

Repayments of revolving credit

facility - (82,625) (724,811)

Payments of redeemable

convertible preferred stock

cash dividends (4,204) (5,600) (5,600)

Excess tax benefits from

exercise of stock options 221 2,255 -

Deferred financing costs - - (459)

Repayments of debt and capital

lease obligations (2,659) (29) (372)

Net cash (used in) provided by

financing activities (4,323) 1,502 (2,296)

Net (decrease) increase in cash and

cash equivalents (7,705) 1,138 3,884

Cash and cash equivalents at

beginning of year 8,410 7,272 3,388

Cash and cash equivalents at end of

year $705 $8,410 $7,272

NATIONAL MEDICAL HEALTH CARD SYSTEMS, INC. AND SUBSIDIARIES

EBITDA RECONCILIATION

$ IN THOUSANDS

Quarters Ended June 30,

2007 2006

Net cash (used in) provided by

operating activities $(2,482) $369

(Benefit) provision for income taxes (1,141) 1,238

Interest income, net (502) (342)

Net change in assets and liabilities 4,019 3,883

Non-cash items to reconcile net

cash from operations to net income (2,131) (295)

EBITDA $(2,237) $4,853

Stock-based compensation expense 767 1,327

EBITDA before stock-based compensation

expense $(1,470) $6,180

NATIONAL MEDICAL HEALTH CARD SYSTEMS, INC. AND SUBSIDIARIES

EBITDA RECONCILIATION

$ IN THOUSANDS

Years Ended June 30,

2007 2006

Net cash provided by operating

activities $3,172 $7,658

Provision for income taxes 1,198 7,015

Interest income, net (1,396) (1,149)

Net change in assets and

liabilities 14,308 12,342

Non-cash items to reconcile net

cash from operations to net

income (7,611) (2,873)

EBITDA $9,671 $22,993

Stock-based compensation expense 3,799 3,240

EBITDA before stock-based

compensation expense $13,470 $26,233

p>Selling, general and administrative ("SG&A") expenses increased $7.0 million, or 36.8 percent, from $19.0 million for the 2006 fiscal fourth quarter to $26.0 million for the 2007 fiscal fourth quarter. This increase is primarily related to (i) $3.0 million net increase in compensation related costs, including a $2.0 million increase in one-time termination benefits incurred in connection with our senior management changes, (ii) $1.5 million increase in bad debts, (iii) $1.0 million increase in professional fees and legal settlement costs related to settlements of various legal issues and increases in other professional fees, (iv) $1.0 million increase in information-technology ("IT") costs which includes a $657,000 impairment loss related to the cancellation of various capitalized projects, and (v) $400,000 increase in other costs.

Our operating loss for the 2007 fiscal fourth quarter was $4.9 million as compared to operating income of $2.8 million for the 2006 fiscal fourth quarter.

Our effective tax rate was 25.9% for the 2007 fiscal fourth quarter, as compared to 39.7% for the 2006 fiscal fourth quarter. The 25.9% effective tax rate provides us with a tax benefit for the 2007 fiscal fourth quarter whereas the 39.7% effective tax rate resulted in tax expense for the 2006 fiscal fourth quarter. The decrease in the effective tax rate is primarily from employee stock options in accordance with SFAS No. 123( R ).

Earnings (loss) before interest, taxes, depreciation and amortization (EBITDA) for the 2007 fiscal fourth quarter was $(2.2) million, as compared to $4.9 million for the 2006 fiscal fourth quarter. EBITDA before stock-based compensation expense for the 2007 fiscal fourth quarter was $(1.5) million, as compared to $6.2 million for the same period last year. EBITDA per adjusted prescription decreased to $(0.42) during the 2007 fiscal fourth quarter from $0.65 during the same period last year. During both the fiscal fourth quarters of 2006 and 2007, NMHC paid $1.4 million of dividends on the series A preferred stock.

Net loss available to common stockholders for the 2007 fiscal fourth quarter was $4.8 million, or ($0.87) per basic and diluted share, as compared to net income available to common stockholders of $369,000, or $0.07 per basic share and diluted share, for the same period last year. For the 2007 fiscal fourth quarter, the Company's weighted-average number of diluted shares outstanding approximated 5.5 million shares, as compared to 5.4 million shares for the same period last year. Both the 2006 and 2007 fiscal fourth quarter calculations do not assume the conversion of approximately 7.0 million shares of redeemable convertible preferred stock as they are anti-dilutive.

"We continue to be engaged in an on-going review of our infrastructure, service offerings and customer base to determine the most appropriate strategic focus for the Company," said Thomas W. Erickson, NMHC's Interim President and CEO. "We expect that this review will enable us to put in place a more cost effective infrastructure capable of delivering superior service to our customers and improved financial performance for our stockholders. More precisely, this process is focused on streamlining our operations, enhancing our product and service offerings and restoring growth in both revenue and operating profitability to the Company. We believe that PBM industry is poised for continued growth and that NMHC's assets and core capabilities provide us with a platform for success in this market."

Fiscal 2007 Financial Review

During the fiscal year ended June 30, 2007, we identified various errors which resulted in a reduction of our operating income of approximately $211,000. These various errors consisted of the following:

-- Rebate errors that resulted in an approximately $1.5 million decrease

in operating income (the "Rebate Error");

-- Claims payable errors that resulted in a $692,000 increase in operating

income. This $692,000 increase is comprised of a $1.5 million increase

in gross profit offset by an $831,000 increase in our selling, general

and administrative expenses (the "Claims Payable Error");

-- An error relating to the accounting treatment for various lease

transactions that resulted in a $584,000 increase in operating income

(the "Lease Error"); and

-- Other errors that resulted in a $14,000 decrease in operating income.

Revenue for the fiscal year ended June 30, 2007 was $679.1 million, as compared to $862.9 million for the same period last year. The 21.3 percent decrease in revenue is primarily the result of a 25.4 percent decrease in the amount of adjusted prescriptions; partially offset by a 5.4 percent increase in the gross revenue per adjusted prescription. Adjusted prescriptions for the fiscal year ended June 30, 2007 were 24.7 million as compared to 33.1 million for the same period last year. The decrease in the amount of adjusted prescriptions is primarily attributable to a 20.9 percent decrease in covered lives during the fiscal year ended June 30, 2007 as compared to the same period last year resulting from the loss of various customers. The increase in revenue per adjusted prescription is primarily the result of a change in customer mix.

For the fiscal year ended June 30, 2007, gross profit was $87.3 million, a 4.5 percent decrease from the $91.4 million for the same period last year. This decrease is primarily the result of a $5.9 million reduction in rebate revenue from our PBM segment (exclusive of the $1.5 million Rebate Error as defined and discussed above) due to the current trends in negotiations with our customers. This decrease in gross profit was partially offset by (i) $443,000 increase in gross profit from our PBM segment, exclusive of rebates, and (ii) $1.4 million increase in gross profit from our Specialty Pharmacy segment. Further, the $1.5 million relating to the Claims Payable Error as defined and discussed above offsets the $1.5 million relating to the Rebate Error as noted above. Primarily due to changes in our customer mix, gross profit as a percentage of revenue, or gross margin, for the fiscal year ended June 30, 2007 increased to 12.9 percent as compared to 10.6 percent for the same period last year.

Gross profit per adjusted prescription for the fiscal year ended June 30, 2007 increased to $3.53 as compared to $2.76 for the same period last year.

For the fiscal year ended June 30, 2007, SG&A expenses increased $11.6 million or 15.3 percent, from $75.9 million to $87.5 million for the same period last year. This increase is primarily the result of (i) $5.8 million net increase in compensation related costs, inclusive of a $2.3 million increase in one-time termination benefits primarily related to our senior management changes, (ii) $2.9 million increase in professional fees and insurance, primarily related to the review of various financial transactions in conjunction with the filings of our Quarterly Report on Form 10-Q for the periods ended December 31, 2006 and September 30, 2006, settlements of various legal proceedings, as well as an increase in our insurance premiums, (iii) $1.2 million increase in IT related costs, which includes a $657,000 impairment loss related to the cancellation of various capitalized projects, (iv) $1.9 million increase in bad debt expense (inclusive of the $831,000 Claims Payable Error as noted above), of which $1.2 million was incurred during the fourth quarter of fiscal 2007, and (v) $384,000 of net increases in other SG&A expenses. These increases were offset by $584,000 related to the Lease Error as defined and discussed above.

NMHC's effective tax rate was 92.9 percent for the fiscal year ended June 30, 2007, as compared to 42.1 percent for the same period last year. The increase in the effective tax rate primarily resulted from lower pre-tax income combined with the effects of expensing stock options in accordance with SFAS 123R offset by a $439,000 reversal of a prior state tax reserve as the related statute of limitations expired during fiscal 2007.

EBITDA for the fiscal year ended June 30, 2007 was $9.7 million, a 57.8 percent decrease, as compared to $23.0 million for the same period last year. EBITDA before stock-based compensation expense for the fiscal year ended June 30, 2007 was $13.5 million as compared to $26.2 million for the same period last year, a 48.5 percent decrease. EBITDA per adjusted prescription decreased to $0.39 during the fiscal year ended June 30, 2007 from $0.69 during the same period last year.

Net loss available to common stockholders for the fiscal year ended June 30, 2007 was $6.0 million, or ($1.10) per basic and diluted share, as compared to net income available to common stockholders of $3.6 million, or $0.70 per basic share and $0.67 per diluted share for the same period last year. For the fiscal year ended June 30, 2007, the Company's weighted-average number of diluted shares outstanding approximated 5.5 million shares, as compared to 5.3 million shares for the same period last year. The calculation for the fiscal years ended June 30, 2007 and 2006 does not assume the conversion of approximately 7.0 million shares of redeemable convertible preferred stock as they are anti-dilutive.

Fiscal 2008 Financial Outlook

Due to NMHC's on-going review of its infrastructure, service offerings and customer base, the Company at this time is not providing fiscal 2008 financial guidance. When NMHC determines it is appropriate, the Company intends to provide the market with an update.

Conference Call

Management will host a conference call tomorrow, September 11th, to discuss their 2007 fiscal fourth quarter and full year results at 8:30 a.m. ET. To listen to the call, please dial 866-800-8649 (U.S. callers) or 617-614- 2703 (international callers), and provide pass code# 23628047. A live webcast of the call will be accessible on the Company's website, http://www.nmhc.com. The webcast will be archived on the site and a telephone replay will be available for seven days beginning at 11:30 a.m. ET. To access the replay, please dial 888-286-8010 (U.S. callers) or 617-801-6888 (international callers) using conference ID: 77554294.

Non-GAAP Measures

In addition to the results presented in accordance with GAAP throughout this press release, NMHC has presented non-GAAP financial measures, such as EBITDA.

NMHC calculates and uses EBITDA as an indicator of their ability to generate cash from their reported operating results. This measurement is used in concert with net income and cash flows from operations, which measure actual cash generated in the period. In addition, we believe that EBITDA is a supplemental measurement tool used by analysts and investors to help evaluate overall operating performance and the ability to incur and service debt and make capital expenditures. EBITDA does not represent funds available for their discretionary use, nor is it intended to represent or to be used as a substitute for net income or cash flows from operations data as measured under GAAP. The items excluded from EBITDA but included in the calculation of their reported net income are significant components of their consolidated statements of income, and must be considered in performing a comprehensive assessment of their overall financial performance. EBITDA, and the associated year-to-year trends, should not be considered in isolation. Their calculation of EBITDA may not be consistent with calculations of EBITDA used by other companies. Reconciliation schedules to the comparable GAAP measures are available on pages 10 and 11.

About NMHC

National Medical Health Card Systems, Inc. provides PBM services to plan customers, which include managed care organizations, local governments, unions, corporations, HMOs, employers, workers' compensation plans, third party health care plan administrators and federal and state government programs through its network of licensed pharmacies throughout the United States. The Company's PBM services include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail service pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access and reporting and information analysis. In addition, the Company owns a mail service pharmacy and a specialty pharmacy and is a national provider of drug benefits to its customers under the federal government's Medicare Part D program.

Forward-Looking Statements

This press release and any attachment thereto contains forward-looking information about National Medical Health Card Systems, Inc.'s financial results and estimates, business prospects, and products and services that involve substantial risks and uncertainties or other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You can identify these statements by the use of words such as "may," "could," "estimate," "will," "believe," "anticipate," "think," "intend," "expect," "project," "plan," "target," "forecast", and similar words and expressions which identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and involve known and unknown risks and uncertainties, and other factors. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, pricing, competition in the bidding and proposal process, our ability to consummate contract negotiations with prospective clients, dependence on key members of management, government regulation, acquisitions and affiliations, the market for PBM services, and the outcome of our on-going review of the Company's infrastructure, service offerings and customer base, readers are urged to carefully review and consider various disclosures made by NMHC in its Annual Report on Form 10-K for the fiscal year ended June 30, 2007, and in its reports on Forms 10-Q and 8-K filed with the U.S. Securities and Exchange Commission. NMHC assumes no obligation to update any forward- looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.

NATIONAL MEDICAL HEALTH CARD SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

June 30, June 30,

Assets 2007 2006

Current:

Cash and cash equivalents $705 $8,410

Restricted cash 19,276 4,845

Accounts receivable, net 62,465 82,365

Rebates receivable 42,417 48,911

Inventory 6,250 5,666

Deferred tax assets 1,913 2,278

Prepaid expenses and other

current assets 2,758 2,623

Total current assets 135,784 155,098

Propert
'/>"/>

SOURCE National Medical Health Card Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
Breaking Medicine Technology: